Preliminary results from a clinical trail with a meningococcal vaccine containing serotype 2b and 15 antigens in complex with mixed A,C, Y and W135 polysaccharides
(1) National Institute of Public Health, 0462 Oslo 4, Norway;(2) Office of Biologics, Food and Drug Administration, USA;(3) Walter Reed Army Institute of Research, Washington, DC, USA